1. Home
  2. ADVM vs BAER Comparison

ADVM vs BAER Comparison

Compare ADVM & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • BAER
  • Stock Information
  • Founded
  • ADVM 2006
  • BAER 2014
  • Country
  • ADVM United States
  • BAER United States
  • Employees
  • ADVM N/A
  • BAER N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • BAER Blank Checks
  • Sector
  • ADVM Health Care
  • BAER Finance
  • Exchange
  • ADVM Nasdaq
  • BAER Nasdaq
  • Market Cap
  • ADVM 66.3M
  • BAER 112.7M
  • IPO Year
  • ADVM 2014
  • BAER N/A
  • Fundamental
  • Price
  • ADVM $3.05
  • BAER $1.81
  • Analyst Decision
  • ADVM Strong Buy
  • BAER Strong Buy
  • Analyst Count
  • ADVM 4
  • BAER 1
  • Target Price
  • ADVM $19.75
  • BAER $5.25
  • AVG Volume (30 Days)
  • ADVM 78.2K
  • BAER 144.3K
  • Earning Date
  • ADVM 11-03-2025
  • BAER 11-10-2025
  • Dividend Yield
  • ADVM N/A
  • BAER N/A
  • EPS Growth
  • ADVM N/A
  • BAER N/A
  • EPS
  • ADVM N/A
  • BAER N/A
  • Revenue
  • ADVM $1,000,000.00
  • BAER $126,489,000.00
  • Revenue This Year
  • ADVM $1,836.70
  • BAER $13.26
  • Revenue Next Year
  • ADVM N/A
  • BAER N/A
  • P/E Ratio
  • ADVM N/A
  • BAER N/A
  • Revenue Growth
  • ADVM N/A
  • BAER 72.69
  • 52 Week Low
  • ADVM $1.78
  • BAER $1.02
  • 52 Week High
  • ADVM $8.56
  • BAER $4.44
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 51.69
  • BAER 49.89
  • Support Level
  • ADVM N/A
  • BAER N/A
  • Resistance Level
  • ADVM $3.59
  • BAER $1.97
  • Average True Range (ATR)
  • ADVM 0.19
  • BAER 0.11
  • MACD
  • ADVM -0.15
  • BAER -0.09
  • Stochastic Oscillator
  • ADVM 84.89
  • BAER 80.58

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF (Super Scooper) aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: